Karen Crawford
Bacterial Toxins
List Biological Labs, Inc.
United States of America
Biography
Dr. Crawford has over twenty-five years experience in biotechnology. She joined List Labs in 1989 and has an extensive background in bacterial fermentation and aerobes and anaerobes, toxin production and purification. Dr. Crawford led the List Labs team to build and commission a cGMP parenteral toxin drug manufacturing facility where she supervised cGMP production and upstream processing of a clostridial toxin. During her appointment as President of List Biological Laboratories, Inc., Dr. Crawford is managing projects providing quality-controlled anthrax and botulinum toxins to a resource repository. In addition, she directs the development of numerous products including C. difficile and Bacillus anthracis toxins and both C. diphtheriae toxin and the CRM mutant.
Research Interest
Bacterial toxins and research reagents
